Skip to main content
. 2020 Feb 18;11:83. doi: 10.3389/fneur.2020.00083

Table 2.

Treatment details of patients with and without first pass effect (FPE).

FPE (N = 140) Non-FPE (N = 469) P-value
Treatment details
Intravenous tPA use, n/N (%) 66/138 (48) 241/467 (52) 0.44
TOG ≤ 6 h, n/N (%) 86/134 (64) 284/453 (63) 0.84
TOG ≤ 8 h, n/N (%) 106/134 (79) 362/453 (80) 0.90
TOG > 8 h, n/N (%) 28/134 (21) 91/453 (20) 0.90
Onset to puncture in minutes, Mean ± SD, Median [IQR] 384.4 ± 352.9, 267.5 [245.25] 358.1 ± 234.8, 285 [244] 0.32
Total procedural time (Groin puncture to final angiogram) in minutes, Mean ± SD; Median [IQR] 49.6 ± 23.7; 46.5 [26.5] 99.7 ± 53.9; 90 [69] <0.0001
Total fluoroscopic time in minutes, Mean ± SD, Median [IQR] 18.5 ± 12.5, 14.6 [10.48] 36.3 ± 23.8, 30 [26] <0.0001
Puncture to reperfusion in minutes, Mean ± SD, Median [IQR] 46.3 ± 27.4, 38 [25.75] 89.3 ± 51, 80 [63] <0.0001
Use of BGC, n (%) 69 (49) 219 (47) 0.63
General anesthesia, n (%) 80 (57) 301 (64) 0.14
Use of rescue therapy, n/N (%) N/A 128/462 (28)
# of passes, Mean ± SD, Median [IQR] N/A 2.2 ± 1.2, 2 [2]

BGC, balloon-guided catheter; IQR, interquartile range; TOG, time of onset to groin puncture; tPA, tissue plasminogen activator. Rows that have mean and median values between groups, p-values correspond to mean, SD values.